Oligonucleotide Synthesis
Market to Reach $2.8 Billion by 2023
www.psmarketresearch.com
Oligonucleotide Synthesis Market
Global oligonucleotide synthesis market is expected to reach $2.8 billion by 2023, the market is
mainly driven by advancements in oligonucleotide synthesis technologies, favorable government
regulations, growing research activities in synthetic biology, and rising prevalence of cancer and
infectious diseases
Explore report at: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesismarket
Based on offering, the oligonucleotide synthesis market is classified into synthesized oligonucleotides,
reagents and consumables, and equipment. During the historical period, synthesized oligonucleotides
held the largest share in the market, accounting for 76.3% in 2017.
“
Copyright © P&S Market Research
Oligonucleotide Synthesis Market
Based on application, the oligonucleotide synthesis market is categorized into research,
diagnostics, and therapeutics. Of these, the fastest growth in the market during the forecast
period is expected from research applications, with a CAGR of 11.1%.
On the basis of end user, the market is categorized into academic research institutes, diagnostic
laboratories, pharmaceutical and biotechnology companies, and others. Others primarily include
food and beverage companies and forensic laboratories. Academic research institutes are
expected to continue holding the largest share in the oligonucleotide synthesis market in the
coming years. They accounted for 40.4% share in the market in 2017.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiryurl=oligonucleotide-synthesis-market
Copyright © P&S Market Research
Oligonucleotide Synthesis Market
In order to increase their market share, key players of the oligonucleotide synthesis industry are
seeking partnerships and acquisitions. For instance, in May 2018, LGC Biosearch Technologies Inc.
(LGC) acquired BioAutomation Corporation (BioAutomation), a manufacturer of MerMade oligo
synthesis instruments. The acquisition followed LGC’s acquisitions of Biosearch, Prime Synthesis,
and LINK Technologies, and is expected to further drive the company’s growth in the
oligonucleotide reagent and synthesized oligonucleotide markets.
Request for report sample at: https://www.psmarketresearch.com/marketanalysis/oligonucleotide-synthesis-market/report-sample
In March 2018, Thermo Fisher Scientific Inc. (Thermo Fisher), acquired IntegenX Inc., a provider of
rapid DNA platforms for use in forensics and law enforcement applications. IntegenX products
have significantly enhanced Thermo Fisher's existing human identification (HID) portfolio and
complemented its leading human identification chemistries, and qPCR and capillary
electrophoresis systems.
Copyright © P&S Market Research
Oligonucleotide Synthesis Market
Some of the other key players operating in the oligonucleotide synthesis industry are General Electric
Company, Merck KGaA, Eurofins Scientific SE, Integrated DNA Technologies Inc., GeneDesign Inc., Trilink
Biotechnologies LLC, Nitto Denko Avecia Inc., and Kaneka Eurogentec S.A.
Copyright © P&S Market Research
THANK YOU!
Click to edit Master title style
For queries, kindly write to:
Edit Master text styles
GET IN TOUCH
[email protected]
www.psmarketresearch.com
B-13, Sector-2, Noida, U.P.-201301, INDIA
Contact No: +91 120 4541 337
US/Canada Toll-Free: 1-888-778-7886
US/Canada Toll-Free: 1-888-778-7886
2/7/2019
6